Blazar BR - Search Results

1

MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.

Koyama M, Mukhopadhyay P, Schuster IS, Henden AS, Hülsdünker J, Varelias A, Vetizou M, Kuns RD, Robb RJ, Zhang P, Blazar BR, Thomas R, Begun J, Waddell N, Trinchieri G, Zeiser R, Clouston AD, Degli-Esposti MA, Hill GR. Koyama M, et al. Among authors: blazar br. Immunity. 2019 Nov 19;51(5):885-898.e7. doi: 10.1016/j.immuni.2019.08.011. Epub 2019 Sep 18. Immunity. 2019. PMID: 31542340 Free PMC article.

2

Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.

Roy J, McGlave PB, Filipovich AH, Miller WJ, Blazar BR, Ramsay NK, Kersey JH, Weisdorf DJ. Roy J, et al. Among authors: blazar br. Bone Marrow Transplant. 1992 Jul;10(1):77-82. Bone Marrow Transplant. 1992. PMID: 1515883

3

Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.

Blazar BR, Thiele DL, Vallera DA. Blazar BR, et al. Blood. 1990 Feb 1;75(3):798-805. Blood. 1990. PMID: 1967541 Free article.

4

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.

Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Weisdorf D, et al. Transplantation. 1991 Jun;51(6):1197-203. doi: 10.1097/00007890-199106000-00010. Transplantation. 1991. PMID: 2048196

5

Kupffer cell engraftment across the major histocompatibility barrier in mice: bone marrow origin, class II antigen expression, and antigen-presenting capacity.

Paradis K, Sharp HL, Vallera DA, Blazar BR. Paradis K, et al. Among authors: blazar br. J Pediatr Gastroenterol Nutr. 1990 Nov;11(4):525-33. doi: 10.1097/00005176-199011000-00014. J Pediatr Gastroenterol Nutr. 1990. PMID: 2262842

6

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Weisdorf D, et al. Blood. 1990 Feb 15;75(4):1024-30. Blood. 1990. PMID: 2302454 Free article.

7

Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.

Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B, Ramsay NK, Kersey JH, Filipovich A. Weisdorf DJ, et al. Blood. 1990 Aug 1;76(3):624-9. Blood. 1990. PMID: 2378989 Free article.

8

FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

Blazar BR, Taylor PA, Fitzsimmons WE, Vallera DA. Blazar BR, et al. J Immunol. 1994 Aug 15;153(4):1836-46. J Immunol. 1994. PMID: 7519216

9

The tissue expression of cytokines in human acute cutaneous graft-versus-host disease.

Roy J, Blazar BR, Ochs L, Weisdorf DJ. Roy J, et al. Among authors: blazar br. Transplantation. 1995 Aug 27;60(4):343-8. doi: 10.1097/00007890-199508270-00008. Transplantation. 1995. PMID: 7652763

10

The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.

Vallera DA, Taylor PA, Sprent J, Blazar BR. Vallera DA, et al. Among authors: blazar br. Transplantation. 1994 Jan;57(2):249-56. doi: 10.1097/00007890-199401001-00017. Transplantation. 1994. PMID: 7906058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

888 results

Search Page